Cargando…

Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China

BACKGROUND: Hand, foot and mouth disease (HFMD) is caused by a variety of enterovirus serotypes and the etiological spectrum worldwide has changed since a large scale of outbreaks occurred in 1997. METHODS: A large number of clinical specimens of HFMD patients were collected in Xiangyang and genotyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Yuting, Luo, Zhiyu, Jin, Weiping, Mai, Jianyi, Qian, Shasha, Lu, Jia, Wei, Zhenni, Meng, Shengli, Wang, Zejun, Guan, Xuhua, Tong, Yeqing, Shen, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611921/
https://www.ncbi.nlm.nih.gov/pubmed/34819054
http://dx.doi.org/10.1186/s12920-021-01107-6
_version_ 1784603385302876160
author Yu, Yuting
Luo, Zhiyu
Jin, Weiping
Mai, Jianyi
Qian, Shasha
Lu, Jia
Wei, Zhenni
Meng, Shengli
Wang, Zejun
Guan, Xuhua
Tong, Yeqing
Shen, Shuo
author_facet Yu, Yuting
Luo, Zhiyu
Jin, Weiping
Mai, Jianyi
Qian, Shasha
Lu, Jia
Wei, Zhenni
Meng, Shengli
Wang, Zejun
Guan, Xuhua
Tong, Yeqing
Shen, Shuo
author_sort Yu, Yuting
collection PubMed
description BACKGROUND: Hand, foot and mouth disease (HFMD) is caused by a variety of enterovirus serotypes and the etiological spectrum worldwide has changed since a large scale of outbreaks occurred in 1997. METHODS: A large number of clinical specimens of HFMD patients were collected in Xiangyang and genotyping was performed by qRT-PCR, conventional PCR amplification and sequencing. Among the 146 CV-A5 detected cases, the complete genome sequences of representative strains were determined for genotyping and for recombination analysis. RESULTS: It was found that CV-A5 was one of the six major serotypes that caused the epidemic from October 2016 to December 2017. Phylogenetic analyses based on the VP1 sequences showed that these CV-A5 belonged to the genotype D which dominantly circulated in China. Recombination occurred between the CV-A5 and CV-A2 strains with a breakpoint in the 2A region at the nucleotide 3791. CONCLUSIONS: The result may explain the emergence of CV-A5 as one of the major pathogens of HFMD. A multivalent vaccine against HFMD is urgently needed to control the disease and to prevent emerging and spreading of new recombinants.
format Online
Article
Text
id pubmed-8611921
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86119212021-11-29 Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China Yu, Yuting Luo, Zhiyu Jin, Weiping Mai, Jianyi Qian, Shasha Lu, Jia Wei, Zhenni Meng, Shengli Wang, Zejun Guan, Xuhua Tong, Yeqing Shen, Shuo BMC Med Genomics Research Article BACKGROUND: Hand, foot and mouth disease (HFMD) is caused by a variety of enterovirus serotypes and the etiological spectrum worldwide has changed since a large scale of outbreaks occurred in 1997. METHODS: A large number of clinical specimens of HFMD patients were collected in Xiangyang and genotyping was performed by qRT-PCR, conventional PCR amplification and sequencing. Among the 146 CV-A5 detected cases, the complete genome sequences of representative strains were determined for genotyping and for recombination analysis. RESULTS: It was found that CV-A5 was one of the six major serotypes that caused the epidemic from October 2016 to December 2017. Phylogenetic analyses based on the VP1 sequences showed that these CV-A5 belonged to the genotype D which dominantly circulated in China. Recombination occurred between the CV-A5 and CV-A2 strains with a breakpoint in the 2A region at the nucleotide 3791. CONCLUSIONS: The result may explain the emergence of CV-A5 as one of the major pathogens of HFMD. A multivalent vaccine against HFMD is urgently needed to control the disease and to prevent emerging and spreading of new recombinants. BioMed Central 2021-11-24 /pmc/articles/PMC8611921/ /pubmed/34819054 http://dx.doi.org/10.1186/s12920-021-01107-6 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yu, Yuting
Luo, Zhiyu
Jin, Weiping
Mai, Jianyi
Qian, Shasha
Lu, Jia
Wei, Zhenni
Meng, Shengli
Wang, Zejun
Guan, Xuhua
Tong, Yeqing
Shen, Shuo
Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title_full Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title_fullStr Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title_full_unstemmed Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title_short Emergence of a novel recombinant of CV-A5 in HFMD epidemics in Xiangyang, China
title_sort emergence of a novel recombinant of cv-a5 in hfmd epidemics in xiangyang, china
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8611921/
https://www.ncbi.nlm.nih.gov/pubmed/34819054
http://dx.doi.org/10.1186/s12920-021-01107-6
work_keys_str_mv AT yuyuting emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT luozhiyu emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT jinweiping emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT maijianyi emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT qianshasha emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT lujia emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT weizhenni emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT mengshengli emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT wangzejun emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT guanxuhua emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT tongyeqing emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina
AT shenshuo emergenceofanovelrecombinantofcva5inhfmdepidemicsinxiangyangchina